To me $NAUT is a classic ALC giga-asymmetry
Chiplets for $AMD back in 2014 projected over a decade plus = trillion dollar company
Iterative mapping today for $NAUT is the same deal
Odds of going to zero, but the asymmetry is beautiful
I went long $AMD at $4.20 a decade ago because I believed chiplets would become the foundation of modern compute.
They did.
$IBRX gives me the same feeling today, but in biotech.
Anktiva isn’t just a fusion protein complex. It’s an operating system for the human immune system.
A decade ago, I went long $AMD at $4.20 because I saw chiplets becoming the foundation of modern compute.
That’s exactly what happened.
Today, $IBRX gives me the same feeling in biotech.
I see Anktiva as far more than a fusion protein complex.
An operating system for the human immune system.
As AI chips move to stacked, chiplet-based architectures, EDA vendors are reworking mature tools for cross-domain analysis, faster exploration, and agentic AI assistance.
#semiconductor# #semiEDA# #3DIC# #AgenticAI# #chiplets#
While the market thought $AMD was a dying CPU company, for many years I said it would grow into an AI giant far surpassing $NVDA in many aspects driven by chiplets
We now get to see this happen
$AMD at the Citi Global TMT Conference
“We haven't given a ton of details yet, but we do have some of our own internal silicon ambitions for ultra-low-latency inference that would fit into our architecture via chiplets.”
The Taalas acquisition and the Cerebras partnership are just $AMD’s baby steps into ultra-low-latency inference
The goal is to develop this silicon in-house going forward, and the trend we’ll likely see is increasingly specialized ASICs designed for specific workloads